swine flu April 30 bio tech companies stand to make hundreds of millions from vaccine,resit taking any vaccine .wash your hands stock up on food now avoid public places.
here are NOVOVAX finacial estamets realesed march notice the excception to there prediction and how it is phrased did they now this was coming? NOVAVAX INC. (NVAX.O) Latest Forecast* No. of Yr ago analysts qtr
EPS (basic, $/shr) -0.10 -- -- 0.13
Net ($ million) -6.1 -- -- 6.2
Total revenue ($ million) 1.3 1.1 3 2.2
*Source: Reuters Estimates
#Excludes extraordinary, special or one-time items
(READ THAT ONE SPECIAL OR ONE TIME ITEMS WTF)
--Novavx said the prior year quarter included a gain in the
sale of product assets as well as a $1 million license renewal
fee received in December 2005.
--For the latest fourth quarter, three analysts on average
expected the biopharmaceutical company to post a loss of 9
cents a share, +++excluding exceptional+++(WTF?) items but including
stock-based compensation, according to Reuters Estimates.
(Reporting by Esha Dey in Bangalore)
Link to this comment:
Video Responses
All Comments (1)